Peijia Medical Limited (4WO) - Total Liabilities

Latest as of June 2025: €614.64 Million EUR ≈ $718.58 Million USD

Based on the latest financial reports, Peijia Medical Limited (4WO) has total liabilities worth €614.64 Million EUR (≈ $718.58 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Peijia Medical Limited to assess how effectively this company generates cash.

Peijia Medical Limited - Total Liabilities Trend (2018–2024)

This chart illustrates how Peijia Medical Limited's total liabilities have evolved over time, based on quarterly financial data. Check 4WO financial resilience to evaluate the company's liquid asset resilience ratio.

Peijia Medical Limited Competitors by Total Liabilities

The table below lists competitors of Peijia Medical Limited ranked by their total liabilities.

Company Country Total Liabilities
OceanPact Serviços Marítimos S.A
SA:OPCT3
Brazil R$2.46 Billion
Shang Hai Ya Tong Co Ltd
SHG:600692
China CN¥3.95 Billion
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
China CN¥1.01 Billion
Miwon Specialty Chemical Co Ltd
KO:268280
Korea ₩106.74 Billion
Enity
ST:ENITY
Sweden Skr32.79 Billion
The Star Entertainment Group Limited
F:EE9
Germany €1.07 Billion
Zhejiang Renzhi Co Ltd
SHE:002629
China CN¥218.60 Million
Jilin Jian Yisheng Pharmaceutical Co Ltd
SHE:002566
China CN¥658.86 Million

Liability Composition Analysis (2018–2024)

This chart breaks down Peijia Medical Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 4WO stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.79 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.31 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.24 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Peijia Medical Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Peijia Medical Limited (2018–2024)

The table below shows the annual total liabilities of Peijia Medical Limited from 2018 to 2024.

Year Total Liabilities Change
2024-12-31 €644.11 Million
≈ $753.03 Million
+61.88%
2023-12-31 €397.88 Million
≈ $465.17 Million
-41.39%
2022-12-31 €678.86 Million
≈ $793.66 Million
+369.85%
2021-12-31 €144.48 Million
≈ $168.92 Million
+112.49%
2020-12-31 €67.99 Million
≈ $79.49 Million
-95.27%
2019-12-31 €1.44 Billion
≈ $1.68 Billion
+435.05%
2018-12-31 €268.70 Million
≈ $314.14 Million
--

About Peijia Medical Limited

F:4WO Germany Medical Devices
Market Cap
$502.76 Million
€430.04 Million EUR
Market Cap Rank
#13638 Global
#1389 in Germany
Share Price
€0.65
Change (1 day)
-2.27%
52-Week Range
€0.57 - €1.01
All Time High
€3.90
About

Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company products inclu… Read more